A proposal for the integration of immunohistochemical staining and DNA- based techniques for the determination of TP53 mutations in human carcinomas

Diagnostic Molecular Pathology

Volumn 9, Issue 1, 2000, Pages 35-40

  Logullo, Angela Flávia ^a   De Moura, Ricardo Pereira ^a   Nonogaki, Sueli ^a,b   Kowalski, Luiz Paulo ^a   Nagai, Maria Aparecida ^a,b,c   Simpson, Andrew J G ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Heteroduplex analysis; Immunohistochemistry; Mutation detection; TP53

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; DNA SEQUENCE; GENE MUTATION; GENETIC SCREENING; HEAD CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENES, P53; HEAD AND NECK NEOPLASMS; HETERODUPLEX ANALYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; MUTATION, MISSENSE; POINT MUTATION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034052878     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200003000-00006     Document Type: Article

References (13)

1. Borrensen AL, Andersen TI, Eyfford JE, et al. TP53 mutations and breast cancer prognosis: particularly poor survival rate for cases with mutations in the zinc-binding domains. Genes Chromosom Cancer 1995;14:71-5.
2. Burns JE, Baird MC, Clarck LJ, et al. Gene mutation and increased levels of the p53 protein in human squamous cell lines. Br J Cancer 1993;67:274-84.
3. Calzolari A, Chiarelli I, Bianchi S, Messerini L, Gallo O, Porfirio B, Mattiuz PL. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol 1997; 107:7-11.
4. Coulter LK, Wolber R, Tron VA. Site-specific comparison of p53 immunostaining in squamous cell carcinomas. Hum Pathol 1995; 26:531-3.
5. Elledge RM. Assessing p53 status in breast cancer prognosis: where should you put the thermometer if your p53 is sick. J Natl Cancer Inst 1996;88:141.
6. Logullo AF, Kowalski LP, Nonogaki S, Miguel RME, Torloni H, Brentani RR. P53 over-expression in epidermoid carcinoma of the head and neck. São Paulo Med J 1997;115:1349.
7. Melham MF, Law JC, El-Ashmawy L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol 1995;146:1170-7.
8. Murakami Y, Hayashi K, Sekita T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res 1991;51:3356-61.
9. Nagai MA, Miracca EC, Yamamoto L, Moura RP, Simpson AJG, Kowalski LP, Brentani RR. TP53 genetic alterations in head-and-neck carcinomas from Brazil. Int J Cancer 1998;76:13-18.
10. Sanguinetti CJ, Dias neto E, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994;17:914-21.
11. Sjögren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
12. Tsuda H, Hirohashi S. Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int J Cancer 1994;57:498-503.
13. Yandele DW, Thor A. P53 analysis in diagnostic pathology. Diagn Mol Pathol 1993;2:1-3.